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http:WHAT THIS PAPER ADDS
The incidence of aortic graft infections has never been closely studied. This study is the ﬁrst to present
contemporary incidence rates of aortic graft infection after primary aortic reconstruction.Objective: The introduction of endovascular techniques has had a major impact on the case mix of patients that
undergo open aortic reconstruction. Hypothetically, this may also have increased the incidence of aortic graft
infection (AGI). The aim of this study was to report on the short and mid-term incidence of AGI after primary
open prosthetic aortic reconstruction in the endovascular era.
Methods: From 2000 to 2010, all 514 patients in a tertiary referral university hospital, undergoing primary open
prosthetic aortic reconstruction for aneurysmal or occlusive aortic disease with at least one aortic anastomosis
were included. Data were obtained by retrospectively analyzing the medical records, by contacting patients or
their general practitioner by telephone, and by merging the dataset with the national Cause of Death Register.
AGI was deﬁned as proven by cultures or clinically in combination with positive imaging results. The 30 day, 1
year, and 2 year incidence rates were computed using life table analysis and expressed as percentages with 95%
conﬁdence intervals (CI).
Results: AGI was diagnosed in 23 of the 514 included patients. 56% of the patients underwent elective surgery and
86% underwent surgery for an abdominal aortic aneurysm.The 30 day incidence was 1.6% (95% CI 0.4e2.8%), 1 year
incidencewas 3.6% (95% CI 1.7e5.5%), and 2 year incidence for AGI was 4.5% (95%CI 2.4e6.6%).The total number of
person years (1058) yielded an AGI rate of 2.2 per 100 person years.
Conclusion: The 2 year cumulative incidence of AGI following primary, open aortic procedures with at least one
aortic anastomosis is considerable, at around 1 in 20.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Currently available data on the incidence of aortic graft in-
fections (AGI) are scarce andmostly refers back to case series
from the mid 1980s. These series are difﬁcult to compare
because they use different deﬁnitions of AGI and have
varying and often limited follow up. Furthermore, most of
these case series did not differentiate patients based on risk
proﬁles for infection, primary or redo operations, and types
of graft material used. According to these studies, the risk of
AGI is between 0.5% and 6%, depending on the type of
procedure.1e15 Completely intra-abdominal grafts are re-
ported to have the lowest risk of AGI (less than 1%), while anof original article: http://dx.doi.org/10.1016/j.ejvs.2015.02.003
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//dx.doi.org/10.1016/j.ejvs.2015.01.001incidence of up to 6% has been reported for grafts with a
groin anastomosis.11,12,14e18 None of these studies, however,
report the time between surgery and diagnosis of infection.
Only one study in the literature could be found reporting on
the incidence of AGI on a time basis.14 This relatively recent
and large population based study, described a 2 year inci-
dence of 0.19% (95% CI 0.12e0.26).This study, however, only
included patients who were surgically treated for AGI,
excluding conservatively treated AGI.
In the mid 1980s, patients with aorto-iliac disease were
mainly treated by open surgery. In more recent decades, the
overall approach for aorto-iliac disease has shifted from
open to endovascular. Nowadays, open reconstructions are
mostly reserved for redo surgery or for patients unsuitable
for endovascular treatment. Consequently, the relative
number of complex open procedures is increasing.
Conversely, the number of patients treated by primary open
surgery and thereby the individual experience of each
vascular surgeon is decreasing. This implies longer operating
582 P. Berger et al.times in a generally sicker patient, potentially increasing the
risk of graft infection.
Various trends in the endovascular era may have further
changed the incidence of AGI. Evolution of medical imaging
has enabled earlier detection of AGI. More attention is
given to the peri-procedural prevention of graft infection
and antibiotic impregnated or silver grafts are being used
prophylactically to treat patients at risk of graft infections.
Expansion of knowledge of the differences in the microor-
ganisms causing early and late graft infections has further
improved (peri-operative) antibiotic coverage.9,10,12
The aim of this study was to provide time related inci-
dence rates of aortic graft infection in patients after primary
aortic surgery in the current endovascular era.
MATERIAL AND METHODS
All patients in a tertiary referral university hospital under-
going prosthetic open aortic reconstructions for aneurysmal
or occlusive aortic disease between January 1, 2000 and
December 31, 2010, were included. Patients were identiﬁed
from the hospital administration system using the Dutch
ﬁnancial coding system for open aortic reconstructions
(Supplementary Table 1). Only patients with primary, open
procedures with at least one aortic anastomosis were
included. All individual operative reports of the index
operation were reviewed to identify patients meeting the
inclusion criteria. The medical charts were reviewed to
obtain pre-deﬁned parameters of basic patient character-
istics, comorbidities, information about the initial operation
(indication, location, type of graft, elective/emergency, and
use of femoral incisions) and graft infection. During the
inclusion period, the peri-operative antibiotic prophylaxis
protocol for aortic surgery was unchanged. Study endpoints
were 30 day, 1 year, and 2 year cumulative incidence rates
of AGI.
Follow up
Follow up data were obtained from the moment of aortic
reconstruction through various sources. Hospital charts and
outpatient records were evaluated. In addition, patients or
their direct relatives were contacted by telephone to ask
whether AGI had occurred since the last hospital visit or
whether the patient had died. When patients could not be
reached, their general practitioners were contacted to
complete missing data. To avoid misdiagnosis by the general
practitioner, each was asked to check their digital infor-
mation system to see whether a patient was admitted toTable 1. Deﬁnitions of AGI.
A. Positive cultures of peri-prosthetic material
obtained by surgery or percutaneous puncture
OR
B. Clinical symptoms of infection such as fever
and elevated infectious parameters in a
patient previously operated on for an aortic
graft without positive cultures of peri-
prosthetic material
And at lea
of the folloanother hospital because of AGI. To further improve mor-
tality data, the dataset was merged with the national Cause
of Death Register (CDR), provided by Statistics Netherlands.
Linkage with the CDR was done anonymously using a
combination of the variables date of birth, sex, and four
digits of the postal code in the year of interest. Only those
that were uniquely linked were included in the present
study. The validity of the CDR has been shown to be
adequate.19 The linkage of the cohort data with the national
statistics data is bound by law to strict rules and privacy
legislation. These rules dictate that results showing data of
less than 10 participants cannot be presented in the pub-
lication because of the potential for identiﬁcation of indi-
vidual patients.
Deﬁnitions
AGI was deﬁned as either, proven by at least one positive
culture of peri-prosthetic material, or at least one positive
culture of a (partially) explanted prosthetic graft, or clini-
cally by a combination of clinical symptoms of infection and
either imaging studies conﬁrming AGI or draining subcu-
taneous sinus with underlying prosthetic vascular graft with
negative cultures (Table 1). All other patients were labeled
unsuspected for AGI. Because of the expected small case
numbers and the privacy legislation, results were not
stratiﬁed by proven or suspected AGI. Early mortality was
deﬁned as mortality within 30 days of the initial surgical
procedure. Comorbidities were deﬁned as recommended by
the Ad Hoc Committee on Reporting Standards.20 Baseline
(T0) was deﬁned as the time of the ﬁrst surgical procedure.
The censoring date was deﬁned as the time of last follow up
contact, the occurrence of the AGI, the end of data acqui-
sition (December 31, 2010) or the time of death, whichever
came ﬁrst. Total person years were calculated from baseline
to the event or censoring date.
Statistical analysis
Baseline characteristics were expressed as percentages with
standard deviation (SD). The incidence of AGI was
computed using life time tables and expressed as percent-
ages with accompanying 95% conﬁdence intervals (95% CI).
Univariate analysis was performed using Cox proportional
hazard regression model to identify independent risk fac-
tors for AGI. Results were expressed as hazard ratios (HR)
and 95% CI. Further multivariate analysis was not per-
formed because the small numbers of patients with AGI
would carry a risk of over-ﬁtting the model.21 Data werePositive cultures of a (partially) explanted
prosthetic graft
st one
wing
1. Imaging studies conﬁrming AGI
2. Draining cutaneous sinus with underlying
prosthetic vascular graft with negative
cultures
Cumulative Incidence of Graft Infections 583collected and processed using the Statistical Package for the
Social Sciences version 20.0 (SPSS, IBM, Armonk, NY, USA).
Patients’ data were analyzed anonymously. Retrospective
patient data research is not within the scope of Dutch law
on human bound research, therefore IRB approval was not
required.RESULTS
In total, 621 patients met the inclusion criteria. Of these,
514 could be linked with the national mortality database.
One hundred and seven patients could not be linked and
were therefore excluded from the present analysis. There
were no major differences in baseline characteristics be-
tween the 107 excluded patients and the ﬁnal cohort
(Supplementary Table 2).
The mean age was 69.2 years (SD 9.5) and 438 (85.2%) of
the patients were male. Of the index operations, 55.8% were
elective and 85.6%were for abdominal aortic aneurysm (AAA).
Mean follow upwas 2.1 years (range 10.9 years).Twenty-three
(4.5%) patients were identiﬁed with AGI.Mortality was high in
patients diagnosedwithAGI (337 per 1000person years). After
being diagnosedwith AGI, 30 daymortality risk was 30% and 1
year mortality risk was 45%.The baseline characteristics of the
study population are shown in Table 2.Incidence of AGI
The 30 day incidence was 1.6% (95% CI 0.4e2.8%), the 1
year incidence 3.6% (95% CI 1.7e5.5%), and 2 yearTable 2. Baseline characteristics.
Variable
Total cohort, N 514
Age, mean (SD) 69.2 (9.5)
N (%)
Sex (male) 438 (85)
AGI 23 (5)
Comorbidities
Diabetic 52 (10)
Hypertension (SVS class 1, 2, or 3) 212 (41)
Cardiac (SVS class 1, 2, or 3) 154 (30)
Pulmonary (SVS class 1, 2, or 3) 79 (15)
Cerebrovascular disease (TIA/CVA) 41 (8)
Operation indication, initial operation
Elective 287 (56)
Abdominal aortic aneurysm 440 (86)
Occlusive aortic disease 68 (13)
Other 6 (1)
Operation type, initial operation
Abdominal tube 295 (57)
Aorto-(bi)-iliac 130 (25)
Aorto-(bi)-femoral 48 (9)
Aorto-iliaco-femoral 11 (2)
Other 30 (6)
Suprarenal clamp 45 (9)
Because of privacy legislation, baseline characteristics could only
be provided for the total group. CVA ¼ cerebral vascular
accident; SVS ¼ Society of Vascular Surgery; TIA ¼ transient
ischemic attack.incidence 4.5% (95% CI 2.4e6.6%). The total number of
person years was 1058, yielding an AGI rate per 100 person
years of 2.2. Median time between the index operation and
the diagnosis of AGI was 83 days (range 1.593 days).Risk factors for AGI
The hazard ratio (HR) of AGI in patients operated on for
aortic aneurysm disease was 2.04 (1.28e3.25). The
following parameters were unrelated to AGI: age, sex, his-
tory of; diabetes, COPD, hypertension, cardiac disease, ce-
rebrovascular disease, elective versus emergency operation,
or the use of a femoral incision (Table 3). As detailed in
Materials and methods, the sample size was considered too
small for a multivariate analysis.DISCUSSION
This study is the ﬁrst to report on the cumulative incidence
of AGI. Incidence estimates of AGI are scarce and difﬁcult to
compare across studies. There are three reasons for this:
deﬁnition of AGI, case selection, and follow up. Incidence
rates depend on how AGI is deﬁned. Positive cultures of
(peri) prosthetic material, obtained by percutaneous punc-
ture or surgery, are the gold standard to prove AGI.10,12,22
However, culture of perigraft material may not be
possible. Obviously, there should be material available for
culturing and even if there is material available around the
graft, it may not be possible to reach it percutaneously. Not
every patient with an AGI will eventually proceed to a
surgical intervention allowing access to material for culture.
Another issue is that culturing of prosthetic vascular ma-
terial, even if found in an evidently infected area, may not
always yield positive results. Therefore, in some patients
with AGI, the diagnosis must be made clinically. There is no
uniform deﬁnition for a clinically proven AGI. The symptoms
of AGI are diverse,23 and may be responsible for differences
in the interpretation of a clinically proven AGI. Most case
series reporting on the incidence of AGI describe highly
selected groups of patient containing only high grade AGI,
which have been treated surgically. Low grade AGI is often
difﬁcult to prove but excluding those from incidence studies
obviously underestimates the true incidence. Surgery is theTable 3. Cox regression univariate analysis, showing the risk for
AGI for various parameters.
Parameter Hazard
ratio
95% conﬁdence
interval
Age 1.00 0.96e1.05
Sex 0.89 0.30e2.60
History of diabetes 1.16 0.35e3.90
History of COPD 2.23 0.92e5.41
History of hypertension 0.43 0.17e1.08
History of cardiac disease 1.25 0.53e2.94
History of cerebrovascular
disease
2.83 0.96e8.34
Elective procedure 0.76 0.30e1.92
Femoral incision 0.47 0.06e3.49
Aneurysmal aortic disease 2.04 1.28e3.25
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tient is considered physically ﬁt enough to withstand a
surgical procedure, and for this reason many patients are
treated conservatively. So by including only surgically
treated AGI patients, the real incidence of AGI is also
underestimated. To improve the accuracy, in the present
study, both microbiologically and clinically proven AGI were
included. To further obtain representative incidence rates,
patients were included regardless of the occurrence of post-
operative complications.
Most of the case-series reporting on incidence rates of
AGI have a mixed patient population. They combine pa-
tients with primary and redo operations and with a diversity
of grafts (mixing aortic with extra-anatomic grafts) and graft
materials (polyester, polytetraﬂuoroethylene [PTFE], or even
autologous material). These factors potentially offer
different risk proﬁles for infection. Therefore, strict inclusion
criteria were applied in this study, namely primary opera-
tions, prosthetic grafts, and at least one aortic anastomosis.
The last difﬁculty in obtaining accurate incidence rates is
adequate patient follow up. Most of the patients with AGI
are treated in tertiary referral centers and it is common
practice that patients are re-directed to their original hos-
pital after treatment. Structured follow up is seldom used.
There is only one recent study in the literature reporting
AGI incidence on a time basis. In this large population based
study, a 2 year incidence rate of 0.19% (95% CI 0.12e0.26%)
was reported in a population of 13,902 patients treated
with open aortic repair.14 As opposed to these results, in
this study a 20 fold greater incidence (2 year incidence rate
of 4.5% [95% CI 2.4e6.6%]) was observed. There are a
number of possible explanations for this discrepancy. First,
in the previous study, patients from several hospitals in the
state of Washington, USA, were included, while the present
study included patients only from one tertiary referral
hospital. This may have caused an overestimation of the
present ﬁndings. Second, in the previous study, only pa-
tients who were surgically treated for AGI were included. As
such, low grade infections or conservatively treated in-
fections are excluded from the incidence estimates, thereby
underestimating true incidence rates. Finally, there is a
difference in the inclusion periods. While in the previous
study, patients were included between 1987 and 2005, the
inclusion period of the present study was 2000 to 2010.
Percutaneous transluminal angioplasty (PTA) of occlusive
aorto-iliac disease did not really take off until the intro-
duction of peripheral stents in the late 1980s. Endovascular
aneurysm repair (EVAR), after being introduced in 1991,
evolved into the preferred treatment for aortic aneurysm in
the ﬁrst decade of the 21st century. The patient population
of the previous study mostly contains patients from the pre-
endovascular era. This is reﬂected by the fact that for the
same time period only 1,276 endovascular aortic pro-
cedures were included in the previous study. Nowadays,
open aortic surgery, is mostly used for redo procedures or
for patients unsuited for endovascular repair. This implies
that current open aortic surgery is more complex with
longer operating times, increasing the risk of AGI.While the present study may have overestimated inci-
dence rates and the previous study may have under-
estimated them, these are the only two signiﬁcant studies
on incidence rates currently available. In view of the evo-
lution of endovascular therapy for both occlusive and
aneurysmal disease, and considering the high incidence
rates in the present study, it might be hypothesized that
endovascular therapy has left open surgery patients at
higher risk for AGI infection. This, however, is speculative.Risk factors for AGI
It is commonly known that patients at risk of infection are
older and have a history of diabetes, COPD, or cardiac dis-
ease. Only a limited number of reports actually studied the
association between risk factors and the occurrence of aortic
graft infection. In a study comparing 51 vascular graft in-
fections (28 aortic and 23 lower extremities) with 102 control
patients, groin incisions were shown to be an independent
risk factor for vascular graft infections with an odds ratio (OR)
of 4.8 (95% CI 1.9e12).24 The same study demonstrated a
non-statistically signiﬁcant trend of an increased risk for
vascular graft infections with emergency procedures (OR 6.6;
95% CI 0.7e60.9). In contrast the present study did not
conﬁrm these risk factors for AGI. In addition, aneurysmal
aortic disease was found to be a risk factor for AGI. However,
this is an unlikely risk factor and there is no clear explanation
for the association. It is important to acknowledge that the
reported associations in both studies are based on a small
sample size, and therefore results should be interpreted with
caution. The potential extra infectious risk of emergency
procedures was n ¼ 217, 44% (HR 0.76, 95% CI 0.30e1.92)
and occlusive disease n ¼ 68, 13% (HR 2.04, 95% CI 1.28e
3.52), and therefore overestimation of incidence rates will
probably be limited in the present study.
There was a trend to culture abdominal aortic aneurysm
sacs routinely peri-operatively (in the 1980s and early
1990s). Positive cultures were found regularly (some studies
reporting up till 40%); however, of the positive cultures,
only very few patients eventually developed aortic graft
infection (0.5e2%).25 Furthermore, there was no relation
between the sac microorganisms and causative graft
infection organisms. Routine culturing of low risk cases was
therefore abandoned at the authors’ hospital, and was not
used in the present study.
The major strengths of this study are the use of a strict
deﬁnition for AGI, the follow up, and themergerwith the CDR
to provide complete mortality data. One limitation of this
study is the patient selection bias. Patients treated in tertiary
teaching hospitals are often more complex cases, with
possibly higher risks of AGI. This selection may have over-
estimated the incidence of AGI in the current study compared
with routine clinical practice. Analyzing patients from a ter-
tiary referral center also means that some patients are
referred back to the referring hospital after treatment
potentially limiting follow up. Furthermore, patients move,
and, even by contacting all general practitioners it is unlikely
that the presented data are 100% complete. It is impossible
Cumulative Incidence of Graft Infections 585to determine how many patients are involved and whether
this balances the above mentioned overestimation. In the
present study, proven and clinically suspected AGI were
combined. As the clinical symptoms of AGI are diverse and
non-speciﬁc,23 there may have been differences in interpre-
tation of a clinically proven AGI. This may be responsible for
some missing cases. Furthermore, some low grade infections
(in which imaging may not [yet] have proved positive) may
have been missed because of the deﬁnition used. This may
have underestimated the reported incidence estimates.
Aorto-bifemoral grafts have an increased risk of infection
compared with strictly abdominal grafts. Because of privacy
legislation, a division between strictly abdominal grafts and
aorto-bifemoral grafts could not be made. Even though only
48 patients with aorto-femoral grafts were identiﬁed, this
may have led to an overestimation of the presented inci-
dence rates.Conclusions
The current 2 year cumulative incidence rate of AGI
following primary, open aortic procedures with at least one
aortic anastomosis is considerable. Almost 1 in 20 patients
develops AGI. Considering the high incidence rates in the
present study, it might be that endovascular therapy has
left open surgery patients at higher risk for AGI infection.
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